Published October 2008

The purpose of this practice parameter o answer the following questions: 1) In patients with TN, how often does routine neuroimaging (CT, MRI) identify a cause? 2) Which features identify patients at increased risk for symptomatic TN (STN; i.e., a structural cause such as a tumor)? 3) Does high-reso

Published December 2015

We evaluated evidence for utility of shunting in idiopathic normal pressure hydrocephalus (iNPH) and for predictors of shunting effectiveness. Reaffirmed on July 12, 2024. The American Association of Neurological Surgeons and the Congress of Neurological Surgeons affirm the educational content of

Published November 2012

This update, developed by the AAN Guideline Development Subcommittee, systematically reviews studies published since June 2000 that are considered relevant to this question: For patients with new-onset Bell palsy, does treatment with steroids or antiviral agents improve facial functional recovery?

Published November 2020

Reaffirmed on October 21, 2023. The scope of this guideline includes prevention of Lyme disease, and the diagnosis and treatment of Lyme disease presenting as erythema migrans, Lyme disease complicated by neurologic, cardiac, and rheumatologic manifestations, Eurasian manifestations of Lyme disea

Published February 2008

In this practice parameter, we attempt to answer these questions: Which neurologic conditions are associated with an increased risk of falling? Are there practical clinical screening methods for neurologists that can accurately identify older patients and those with chronic neurologic conditions who

Published November 2017

The goal of this guideline is to systematically review the evidence and make recommendations with regard to diagnostic utility of cervical and ocular vestibular evoked myogenic potentials (cVEMP and oVEMP, respectively). Reaffirmed on February 10, 2024.

Published March 2007

The Therapeutics and Technology Assessment subcommittee found that epidural steroid injections may offer limited short-term relief for radicular lumbosacral pain but do not improve long-term function or reduce the need for surgery, and their routine use is not recommended. There is also insufficient

Published December 2021

This guideline updates the 2011 AAN practice guideline on the treatment of painful diabetic neuropathy. For patients with painful diabetic neuropathy, clinicians should review all of the available options to reduce pain, including oral, topical, and nonpharmacologic interventions. It is important fo

Published January 2010

This assessment summarizes evidence on the efficacy of TENS in the treatment of pain, specifically the pain associated with neurologic disorders. Reaffirmed on April 15, 2024.